1813 Stock Overview
Processes, manufactures, imports and exports, and sells various lenses, optical instruments, and medical equipment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Polylite Taiwan Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$19.35 |
| 52 Week High | NT$21.50 |
| 52 Week Low | NT$19.00 |
| Beta | 0.26 |
| 11 Month Change | -3.01% |
| 3 Month Change | -3.25% |
| 1 Year Change | -3.25% |
| 33 Year Change | 9.32% |
| 5 Year Change | -32.58% |
| Change since IPO | -31.03% |
Recent News & Updates
Shareholder Returns
| 1813 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | 1.3% | 0.4% | 1.6% |
| 1Y | -3.3% | 6.6% | 36.6% |
Return vs Industry: 1813 underperformed the TW Medical Equipment industry which returned 6.6% over the past year.
Return vs Market: 1813 underperformed the TW Market which returned 36.4% over the past year.
Price Volatility
| 1813 volatility | |
|---|---|
| 1813 Average Weekly Movement | 2.3% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.2% |
| 10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 1813 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1813's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | n/a | n/a | www.gialens.com.tw |
Polylite Taiwan Co., Ltd. processes, manufactures, imports and exports, and sells various lenses, optical instruments, and medical equipment worldwide. Its GIA polycarbonate lenses, including FSV, SFSV, progressive, KID, and polarized lenses. The company was founded in 1982 and is based in Taoyuan City, Taiwan.
Polylite Taiwan Co., Ltd. Fundamentals Summary
| 1813 fundamental statistics | |
|---|---|
| Market cap | NT$902.40m |
| Earnings (TTM) | NT$3.97m |
| Revenue (TTM) | NT$335.19m |
227.5x
P/E Ratio2.7x
P/S RatioIs 1813 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1813 income statement (TTM) | |
|---|---|
| Revenue | NT$335.19m |
| Cost of Revenue | NT$360.81m |
| Gross Profit | -NT$25.62m |
| Other Expenses | -NT$29.59m |
| Earnings | NT$3.97m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.085 |
| Gross Margin | -7.64% |
| Net Profit Margin | 1.18% |
| Debt/Equity Ratio | 35.0% |
How did 1813 perform over the long term?
See historical performance and comparison